168 related articles for article (PubMed ID: 7777386)
1. [Biological aspects of Creutzfeldt-Jakob disease related to the extractive growth hormone].
Deslys JP
Pathol Biol (Paris); 1995 Feb; 43(2):97-103. PubMed ID: 7777386
[TBL] [Abstract][Full Text] [Related]
2. Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development.
Mitrová E; Belay G
Acta Virol; 2002; 46(1):31-9. PubMed ID: 12197632
[TBL] [Abstract][Full Text] [Related]
3. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease.
Deslys JP; Marcé D; Dormont D
J Gen Virol; 1994 Jan; 75 ( Pt 1)():23-7. PubMed ID: 8113733
[TBL] [Abstract][Full Text] [Related]
4. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.
Rudge P; Jaunmuktane Z; Adlard P; Bjurstrom N; Caine D; Lowe J; Norsworthy P; Hummerich H; Druyeh R; Wadsworth JD; Brandner S; Hyare H; Mead S; Collinge J
Brain; 2015 Nov; 138(Pt 11):3386-99. PubMed ID: 26268531
[TBL] [Abstract][Full Text] [Related]
5. Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease.
Shibuya S; Higuchi J; Shin RW; Tateishi J; Kitamoto T
Ann Neurol; 1998 Jun; 43(6):826-8. PubMed ID: 9629853
[TBL] [Abstract][Full Text] [Related]
6. Mutation in codon 200 and polymorphism in codon 129 of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease.
Gabizon R; Rosenman H; Meiner Z; Kahana I; Kahana E; Shugart Y; Ott J; Prusiner SB
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):385-90. PubMed ID: 7913755
[TBL] [Abstract][Full Text] [Related]
7. Human growth hormone and Creutzfeldt-Jakob disease.
Zekauskas S; Boggs MB; Wilson DP
J Okla State Med Assoc; 1990 Sep; 83(9):447-8. PubMed ID: 2280278
[TBL] [Abstract][Full Text] [Related]
8. [Creutzfeldt-Jakob disease in 4 children treated with growth hormone].
Billette de Villemeur T; Gourmelen M; Beauvais P; Rodriguez D; Vaudour G; Deslys JP; Dormont D; Richard P; Richardet JM
Rev Neurol (Paris); 1992; 148(5):328-34. PubMed ID: 1448646
[TBL] [Abstract][Full Text] [Related]
9. [Prion, from crazy cows to iatrogenic Creutzfeldt-Jakob disease. Which risk in laboratory or in hospital?].
Paul J
Pathol Biol (Paris); 1995 Feb; 43(2):114-20. PubMed ID: 7777380
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the prion protein gene and in the doppel gene increase susceptibility for Creutzfeldt-Jakob disease.
Croes EA; Alizadeh BZ; Bertoli-Avella AM; Rademaker T; Vergeer-Drop J; Dermaut B; Houwing-Duistermaat JJ; Wientjens DP; Hofman A; Van Broeckhoven C; van Duijn CM
Eur J Hum Genet; 2004 May; 12(5):389-94. PubMed ID: 14970845
[TBL] [Abstract][Full Text] [Related]
11. Genetic epidemiology of Creutzfeldt-Jakob disease in Europe.
EUROCJD Group
Rev Neurol (Paris); 2001 Jul; 157(6-7):633-7. PubMed ID: 11458182
[TBL] [Abstract][Full Text] [Related]
12. A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein.
Hainfellner JA; Parchi P; Kitamoto T; Jarius C; Gambetti P; Budka H
Ann Neurol; 1999 Jun; 45(6):812-6. PubMed ID: 10360778
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted MRI in familial Creutzfeldt-Jakob disease with the codon 200 mutation in the prion protein gene.
Tsuboi Y; Baba Y; Doh-ura K; Imamura A; Fujioka S; Yamada T
J Neurol Sci; 2005 May; 232(1-2):45-9. PubMed ID: 15850581
[TBL] [Abstract][Full Text] [Related]
14. [Three patients from two families with familial Creutzfeldt-Jakob disease having a point mutation in the prion protein gene at codon 200 (Glu-->Lys)].
Iwabuchi K; Endoh S; Hagimoto H; Okamoto K; Miyakawa T; Yamaguchi T; Kajiwara A; Inoue K; Yamada Y; Amano N
No To Shinkei; 1994 Apr; 46(4):349-54. PubMed ID: 7912945
[TBL] [Abstract][Full Text] [Related]
15. [Biology of non-conventional transmissible agents or prions].
Dormont D
Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of the PrP gene in a Tunisian family with Creutzfeldt-Jakob disease].
Laplanche JL; Chatelain J; Thomas S; Brown P; Cathala F
Rev Neurol (Paris); 1991; 147(12):825-7. PubMed ID: 1780610
[TBL] [Abstract][Full Text] [Related]
17. [A case of Creutzfeldt-Jakob disease with a point mutation of prion protein at codon 180].
Tanaka T; Kinoshita I; Saitoh Y; Satoh K; Nishiura Y; Shirabe S; Kitamoto T
No To Shinkei; 2004 Dec; 56(12):1025-8. PubMed ID: 15729879
[TBL] [Abstract][Full Text] [Related]
18. Distribution of the M129V polymorphism of the prion protein gene in a Turkish population suggests a high risk for Creutzfeldt-Jakob disease.
Erginel-Unaltuna N; Peoc'h K; Komurcu E; Acuner TT; Issever H; Laplanche JL
Eur J Hum Genet; 2001 Dec; 9(12):965-8. PubMed ID: 11840201
[TBL] [Abstract][Full Text] [Related]
19. Creutzfeldt-Jakob disease risk in Slovak recipients of human pituitary growth hormone.
Mitrova E; Belay G
Bratisl Lek Listy; 1999 Apr; 100(4):187-91. PubMed ID: 10914140
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetics of human prion diseases.
Collinge J; Palmer MS
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):371-8. PubMed ID: 7913754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
